â‚©
1500.00
Jun 7
Business Description
ChoA Pharmaceutical Co Ltd
ISIN : KR7034940007
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.3 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.58 | |||||
Debt-to-EBITDA | -1.87 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.5 | |||||
Beneish M-Score | -3.33 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.6 | |||||
3-Year EPS without NRI Growth Rate | -83.2 | |||||
3-Year FCF Growth Rate | -11.6 | |||||
3-Year Book Growth Rate | -11.1 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 10.53 | |||||
9-Day RSI | 16.44 | |||||
14-Day RSI | 22.78 | |||||
6-1 Month Momentum % | -21.88 | |||||
12-1 Month Momentum % | -28.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.41 | |||||
Quick Ratio | 0.97 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 111.1 | |||||
Days Sales Outstanding | 120.39 | |||||
Days Payable | 39.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -2.08 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 35.92 | |||||
Operating Margin % | -13.43 | |||||
Net Margin % | -19.61 | |||||
FCF Margin % | -4.3 | |||||
ROE % | -25.92 | |||||
ROA % | -15.45 | |||||
ROIC % | -12.74 | |||||
ROC (Joel Greenblatt) % | -26.98 | |||||
ROCE % | -23.55 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.76 | |||||
PB Ratio | 1.16 | |||||
Price-to-Tangible-Book | 1.2 | |||||
EV-to-EBIT | -5.12 | |||||
EV-to-EBITDA | -5.12 | |||||
EV-to-Revenue | 1.01 | |||||
EV-to-FCF | -23.48 | |||||
Price-to-Projected-FCF | 4.41 | |||||
Price-to-Median-PS-Value | 0.34 | |||||
Price-to-Net-Current-Asset-Value | 5.93 | |||||
Earnings Yield (Greenblatt) % | -19.52 | |||||
FCF Yield % | -5.77 | |||||
Forward Rate of Return (Yacktman) % | -14.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
ChoA Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 62,263.864 | ||
EPS (TTM) (â‚©) | -394 | ||
Beta | 0.72 | ||
Volatility % | 22.82 | ||
14-Day RSI | 22.78 | ||
14-Day ATR (â‚©) | 37.062567 | ||
20-Day SMA (â‚©) | 1585.25 | ||
12-1 Month Momentum % | -28.9 | ||
52-Week Range (â‚©) | 1490 - 2410 | ||
Shares Outstanding (Mil) | 30.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ChoA Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ChoA Pharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
ChoA Pharmaceutical Co Ltd Frequently Asked Questions
What is ChoA Pharmaceutical Co Ltd(XKRX:034940)'s stock price today?
When is next earnings date of ChoA Pharmaceutical Co Ltd(XKRX:034940)?
Does ChoA Pharmaceutical Co Ltd(XKRX:034940) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |